orally bioavailable bpc 157 Sublingual BPC-157 BPC-157 –
Description
-syn mutant overexpression in DA cells like PC12 and SH-SY5Y severely impairs proteasomal protein cleavage [140]

What the research firmly supports: BPC-157's gut healing, vascular, and neuroprotective mechanisms (strong preclinical evidence) Thymosin Alpha-1's immune modulating and T-cell restorative effects (strong preclinical + clinical evidence in viral disease) TB-500's cardiovascular repair and angiogenic properties (strong preclinical, early human data) What the research does not yet confirm: Randomised controlled trial data specifically in long COVID populations Optimal dosing, sequencing, and duration specifically for PASC Long-term safety data for extended post-viral use This doesn't mean these peptides don't work for long COVID

Think of it as trying to send a vital message through a chaotic, crowded room
If you suspect a deficiency, consult your healthcare provider

J.GaskinsH

Beeman, N., Webb, P
